Active Pharmaceutical Ingredient (API)

Marstacimab

Anti-TFPI Monoclonal Antibody

A once-weekly subcutaneous treatment for hemophilia A or B without inhibitors. Inhibits Tissue Factor Pathway Inhibitor.
Technical Profile
Reference Code
HEM1026
CAS Number
2169507-69-5
Molecular Weight
148,000.00 g/mol
Chemical Class
N/A
Molecular Formula
Variable
Therapeutic Class
N/A

Verified Brands

Medicines containing Marstacimab as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.